The First State’s growing biosciences industry has its roots in the 1992 creation of the Delaware Technology Park, state life sciences and technology advocates told a Senate committee today. Today, that sector of the economy is responsible for 11,000 jobs with $2 billion in gross domestic product, said Mike Fleming, president of DelawareBio, which advocates for and offers support to …
A Newark vaccine company will spend $8 million to expand in Delaware, adding 63 jobs over the next three years. Uvax Bio, considered an early stage biopharmaceutical company with cutting-edge vaccine platform technology, has been headquartered in Newark since 2018. where it has five employees. Its platform has produced both COVID-19 and HIV-1 vaccine candidates. The new positions will …
